Amyloid plaque load analysis in triple-mutant mouse brains

Exploratory Score: 0.880 Price: $0.50 Alzheimer's disease APP/PSEN1/GD3S-/- triple-transgenic mouse brains Status: proposed

What This Experiment Tests

Exploratory experiment designed to discover new patterns targeting St8sia1 in APP/PSEN1/GD3S-/- triple-transgenic mouse brains. Primary outcome: amyloid plaque load reduction

Description

Brain tissue from APP/PSEN1/GD3S-/- triple-mutant mice was examined for amyloid-beta plaque formation and associated neuropathology. The analysis included assessment of both aggregated and unaggregated Abeta levels using histological and biochemical methods. Brain sections were processed for amyloid plaque visualization and quantification, comparing plaque burden between triple-mutant mice and APP/PSEN1 control mice. The study revealed that elimination of GD3S resulted in almost complete elimination of Abeta aggregation and associated neurodegeneration, providing neuropathological evidence supporting the behavioral improvements observed in these mice.

TARGET GENE
St8sia1
MODEL SYSTEM
APP/PSEN1/GD3S-/- triple-transgenic mouse brains
ESTIMATED COST
$0
TIMELINE
0 months
PATHWAY
amyloid aggregation and ganglioside interaction pathway
SOURCE
extracted_from_pmid_18258340
PRIMARY OUTCOME
amyloid plaque load reduction

Scoring Dimensions

Info Gain 0.00 (25%) Feasibility 0.00 (20%) Hyp Coverage 0.00 (20%) Cost Effect. 0.00 (15%) Novelty 0.00 (10%) Ethical Safety 0.00 (10%) 0.880 composite

📖 Wiki Pages

PSEN1 Protein (Presenilin-1)proteinAPP ProteinproteinAPP/PS1 Dual Transgenic Mouse ModelmodelPSEN1 Presenilin 1 AD Causal ChainmechanismAPP/PS1 Double Transgenic Mouse ModelmechanismAPP Processing and Amyloid-Beta ProductionmechanismAPP-BACE1-Fe65 ComplexmechanismAPP Amyloid Pathway in Alzheimer's DiseasemechanismAPP→Amyloid-beta→Plaque→Alzheimer's Disease CausalpathwayAPP Gene Dosage Reduction Therapy for Down SyndromideaPSEN1 — Presenilin 1geneAPP — Amyloid Precursor ProteingenePSEN1 (Redirect)redirectAPP GenegenePSEN1 Mutations in Alzheimer's Diseasedisease

Protocol

Brain tissue harvesting, histological processing, amyloid plaque staining and quantification, neuropathology assessment

Expected Outcomes

Dramatic reduction in amyloid plaque formation and associated neuropathology

Success Criteria

Almost complete elimination of aggregated and unaggregated Abeta

Related Hypotheses (0)

No related hypotheses

Debate History (0)

No debates yet

Experiment Results (0)

No results recorded yet. Use POST /api/experiments/{id}/results to record a result.